Program Schedule

PW1
Best Practices for Antimicrobial Stewardship Programs $

Tuesday, October 7, 2014: 7:30 AM-4:30 PM
Room: The Pennsylvania Convention Center: 121-ABC
Co-organized in collaboration with the Centers for Disease Prevention and Control

Learning Objectives:

At the conclusion of this activity, participants should be able to:

  • evaluate components of effective antimicrobial stewardship programs and implement interventions in their healthcare setting
  • review and apply strategies for and implementing process and outcomes measures
  • apply antimicrobial stewardship interventions for unique populations, including outpatient settings, long-term care facilities, and pediatric populations
  • critically assess available data, including pharmacy and microbiology data, and the informatics strategies needed to support antimicrobial stewardship in their institution

Target Audience: Pharmacists, Microbiologists, Infectious diseases physicians, Infectious diseases pediatricians, Epidemiologists

Tracks: Pediatric ID, Investigative ID, Epidemiology and Infection Control, Adult ID

Pre-Meeting Workshop Moderators:  Tamar Barlam, MD, MSc, FIDSA, FSHEA, Boston Medical Center, Boston University School of Medicine , Sara Cosgrove, MD, MS, FIDSA, FSHEA, The Johns Hopkins University School of Medicine and Pranita D. Tamma, MD, MHS, The Johns Hopkins University School of Medicine

Presentations:
7:30 AM
8:30 AM
Q&A
9:20 AM
Q&A
9:35 AM
Q&A
9:40 AM
10:20 AM
Q&A
10:55 AM
Q&A
11:35 AM
Q&A
11:40 AM
12:00 PM
W7
Managing Outlier Physicians
Christopher Ohl, MD
12:20 PM
Q&A
12:50 PM
Q&A
1:30 PM
Q&A
1:35 PM
W10
Antifungal Stewardship
Dionissios Neofytos, MD
Presentations
  • Neofytos_Antifungal Stewardship.pdf (356.2 kB)
  • 2:05 PM
    Q&A
    2:10 PM
    2:50 PM
    Q&A
    3:25 PM
    Q&A
    3:30 PM
    W12
    3:55 PM
    Q&A

    CME Credits: Maximum of 7.5 hours of AMA PRA Category 1 CreditTM

    ACPE Credits: ACPE 7.5 knowledge-based contact hours (0.75 CEU) of pharmacy CE

    ACPE Number: 0221-9999-14-085-L04-P

    Disclosures:

    T. Barlam, None

    A. Srinivasan, None

    S. Cosgrove, None

    N. O. Fishman, None

    T. Barlam, None

    P. D. Tamma, None

    C. Ohl, None

    K. Hamilton, None

    K. K. Trivedi, None

    M. E. Nepps, None

    K. Carroll, None

    D. Neofytos, Astellas: Consultant and Scientific Advisor, Consulting fee and Speaker honorarium
    Roche Diganostics: Scientific Advisor, Consulting fee
    Pfizer: Research Contractor, Research grant

    E. Dodds Ashley, None

    See more of: Premeeting Session
    << Previous Session | Next Session >>

    Findings in the abstracts are embargoed until 12:01 a.m. EDT, Oct. 8th with the exception of research findings presented at the IDWeek press conferences.

    Sponsoring Societies:

    © 2014, idweek.org. All Rights Reserved.

    Follow IDWeek